Category hc Glossary

Search the Term, Company Name, Ticker, else..

A

B

A	B	C	D	E	F	G	H	I
J	K	L	M	N	O	P	Q	R
S	T	U	V	W	X	Y	Z

Health Care Terms



	Adenocarcinoma				LDL
	Adenosine				Leucopenia
	Adult Stem Cell				Lysate
	Adverse Event				Lysates
	Agonist				Mammography
	AIDS				Marker
	Alkylation Agent				Mast Cells
	Allogeneic				Maximum Tolerated Dose
	Amino Acid				Metastasis
	Analgesic				Milestone
	Analogues				Molecule
	ANDA Abbreviated New Drug Application				Monoclonal Antibody
	Angina				Mutation
	Angiogenesis				NDA or New Drug Application
	Angioplasty				Neuroscience
	Antagonist				Neurotransmitter
	Anti Hypertensive				Neutropenia
	Antibody				Nucleic Acid
	Antigen				Off-Label
	API				Oncology
	Arrhythmia				Open-label Clinical Trial
	Arteriosclerosis				Orphan Drug
	Atherosclerosis				Osteoarthritis
	Autologous				Osteonecrosis
	Balloon Angioplasty				Paediatric Exclusivity
	Bioavailability				Partial Remission PR
	Biologic Products				Passive Immunotherapy
	Biomarker				Patent Term Extension
	Bradycardia				Pathogen
	Cancer				PBM
	Cancer Stem Cell				Pharmacokinetics
	Carcinomas				Pharmacology
	Cardiovascular				Phase I Clinical Trial
	Cardiovascular Disease CVD				Phase II Clinical Trial
	Cell Growth				Phase IIb Clinical Trial
	Cellular Differentiation				Phase III Clinical Trial
	Chemotherapy				Phenotype
	Cholesterol				Pivotal study or Pivotal trial
	Clinical Data				Plasma
	Clinical Development				PMA Pre-Marketing Approval
	Colonoscopy				Pooled Analysis
	Complete Response Letter				Pre-clinical
	Compound				Preclinical Data
	Computer Aided Drug Design				Preclinical Development
	Confirmed Complete Remission CR				Product Candidate
	Controlled Clinical Trial				Prognosis
	Coronary Artery Disease CAD				Prospective Clinical Trial
	Coronary Heart Disease CHD				Proteins
	CRADA				Protocol
	CTA				PS2 Patient
	Cytokine				Qualified Person
	Cytotoxicity				Radiolabeling
	DEA Drug Enforcement Administration				Radiopharmaceutical
	Diagnostic				Randomized Clinical Trial
	Dialysis				Reagent
	DNA Deoxyribonucleic Acid				Receptor
	Dopamine				RECIST
	Double-Blind Clinical Trial				Recombinant
	Drug				Refractory
	Drug Candidate				Regeneration
	Endocrine				Regulatory Health Authorities
	Endpoint				Renal Kidney
	Enzymes				Resistance
	Fast Track				Respiratory
	FDA Food and Drug Administration				Retrovirus
	Formulation				Second-line
	Gene				Sensitivity
	Gene Products				Side-Effect
	Genomics				Small Molecule Drug
	Genotype				Somatic Cell
	Gland				Special Protocol Assessment or SPA
	Glioblastoma Multiforme GBM				Spectrophotometer
	Good Manufacturing Practice GMP				Standard of Care Treatment
	Hazard Ratio HR				Stem Cell
	HDL Cholesterol				Stenting
	Hematopoietic Stem Cells				Sterol
	Hemodialysis				Strain Bacterial
	Hemofiltration Hemofiltrate				T cell
	Hepatitis				Therapeutic
	HIV				Therapeutic Products Directorate TPD
	HMO Health maintenance organization				Toxicity
	Homocysteine				Tuberculosis TB
	Hypercholesterolemia				Unconfirmed complete remission CRu
	Hyperlipoproteinemia				Urology
	Immunocytochemistry				Vaccine
	Immunogenic				Vascular
	Immunoglobulin IgG				Vascular Access
	In-vitro				Vasoactivity
	In-vivo				WBC
	Investigational Medicinal Product Dossier IMPD				Western Blot Analysis
	Investigational New Drug IND				WHO
	Isotoxic				Xenograft